Ensol Biosciences Inc. (XKON:140610)
13,000
-110 (-0.84%)
At close: May 14, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 176.1 billion as of May 15, 2026. Its market cap has decreased by -44.69% in one year.
Market Cap
176.10B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
13,000.00
Market Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 176.10B, an increase of 65.81%. That is a compound annual growth rate of 6.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 176.10B | 0.29% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 258.62B |
| Bio Solution | 247.72B |
| ViGenCell | 245.99B |
| ABION | 193.27B |
| ISU Abxis | 168.58B |
| CORESTEMCHEMON | 166.13B |
| Prestige Biologics | 163.28B |
| QuadMedicine | 131.13B |